What is the significance of an MCHC of 31.3 g/dL and an RDW of 16.3 % in a primary‑care patient, and how should these findings be evaluated and managed?

Evaluation of MCHC 31.3 g/dL and RDW 16.3%

These values suggest iron deficiency anemia (IDA) and warrant immediate investigation with serum ferritin and transferrin saturation to confirm iron deficiency, followed by evaluation for underlying causes including gastrointestinal pathology.

Interpretation of Laboratory Values

Your patient's results show:

• MCHC 31.3 g/dL: Below normal (normal range 32-36 g/dL), indicating hypochromia
• RDW 16.3%: Elevated (normal <14.5-15%), indicating anisocytosis (variation in red cell size)

This combination is highly suggestive of iron deficiency. RDW >16.1% has been validated as a predictive cut-off for iron deficiency with good accuracy 1. The elevated RDW reflects the mixed population of older normocytic cells and newer microcytic cells being produced under iron-deficient conditions. The low MCHC indicates reduced hemoglobin concentration within red cells, a hallmark of iron deficiency 2.

Immediate Diagnostic Workup

Order these tests now:

1. Complete blood count with MCV and MCH - Look for MCV <76 fl and MCH <24 pg, which further support IDA 1
2. Serum ferritin - The gold standard for iron stores
3. Transferrin saturation - Calculated from serum iron and total iron binding capacity
4. Hemoglobin level - To determine if anemia is present

The combination of RDW, MCV, and MCH shows the best correlation with iron parameters, superior to MCHC alone 3.

Differential Diagnosis Considerations

While iron deficiency is most likely, elevated RDW with low MCHC can also indicate:

• Hereditary spherocytosis: However, this typically shows MCHC >34.5 g/dL (elevated, not low), making it unlikely here 4
• Thalassemia minor: Usually has normal or elevated RDW <16%, making this less likely 2
• Mixed deficiency states: Combined iron and B12/folate deficiency

The low MCHC essentially rules out hereditary spherocytosis and makes iron deficiency the primary concern.

Risk Stratification

The RDW of 16.3% carries prognostic significance beyond just diagnosing anemia. RDW >16 achieves 90% specificity for hospital admission risk, and RDW >18.5 achieves 90% specificity for in-hospital mortality across all-cause emergency visits 5. While your patient's value is not critically elevated, it signals the need for thorough evaluation.

Investigation for Underlying Cause

Once iron deficiency is confirmed, investigate the source:

GI Evaluation (Most Common)

• Bidirectional endoscopy (EGD and colonoscopy) is warranted for adults with confirmed IDA 6
• This is the standard approach unless there are clear alternative explanations (e.g., menorrhagia in premenopausal women, known malabsorption)

Consider These Specific Scenarios:

Chronic kidney disease: Check creatinine/eGFR. If CKD present, different thresholds apply - ferritin <100 μg/L (predialysis) or <200 μg/L (hemodialysis) with transferrin saturation ≤20% defines iron deficiency 6

Heart failure: Screen if cardiac symptoms present. In CHF, ferritin <100 μg/L and/or transferrin saturation <20% indicates iron deficiency requiring IV iron therapy regardless of anemia 6

Inflammatory bowel disease: Consider if GI symptoms present. Ferritin up to 100 μg/L may still reflect iron deficiency in the presence of inflammation 6

Common Pitfalls to Avoid

• Don't rely on MCHC alone - It has poor sensitivity and specificity compared to RDW, MCV, and MCH 3
• Don't skip ferritin testing - Clinical indices alone cannot definitively diagnose iron deficiency 2
• Don't assume dietary insufficiency - In adults, IDA usually indicates blood loss requiring investigation 6
• Don't use discriminant functions to avoid further workup - Even the best formulas fail to resolve diagnosis in 67% of cases 2

Treatment Approach

Hold treatment decisions until iron studies confirm the diagnosis. Once confirmed:

• Oral iron supplementation is first-line for uncomplicated IDA
• IV iron is indicated for malabsorption, intolerance, or specific conditions (CHF, CKD on dialysis) 6
• Address underlying cause concurrently